Construction and delivery of gene therapy vector containing soluble TNFα receptor-IgGFc fusion gene for the treatment of allergic rhinitis

Cytokine

Volumn 36, Issue 5-6, 2006, Pages 296-304

  He, Jie ^a   Wang, Tong ^b   Yao, Lihong ^a   Chen, Aijun ^a   Zhou, Bing ^b   Yu, Hong ^a   Jia, Runqing ^a   Cheng, Congsheng ^a   Huan, Lifang ^a   Zhang, Zhiqing ^a  

^a NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Allergic rhinitis; EBV based vector; Gene therapy; Soluble TNF receptor

Indexed keywords

HERPESVIRUS VECTOR; HYBRID PROTEIN; INTERLEUKIN 5; PLACEBO; PLASMID VECTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR IMMUNOGLOBULIN FC FRAGMENT PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOLYSIS; ENDOTHELIUM CELL; EOSINOPHIL COUNT; FUSION GENE; GENE EXPRESSION; GENE TRANSFER; MALE; MAST CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; SYMPTOM; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; NASAL MUCOSA; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY; RHINITIS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; HUMAN HERPESVIRUS 4; MUS;

EID: 34047257824     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.02.010     Document Type: Article

References (23)

1. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palladino Jr. M.A., and Goeddel D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88 20 (1991) 9292-9296
2. Adeka D., Engelmann H., Shemer-Avni I., Hornik V., Galil A., Sarov B., et al. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 11 3 (1992) 157-159
3. Aggarwal B.B., Shishodia S., Ashikawa K., and Bharti A.C. The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Curr Drug Targets Inflamm Allergy 1 4 (2002) 327-341
4. Iwasaki M., Saito K., Takemura M., Sekikawa K., Fujii H., Yamada Y., et al. TNF-α contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 112 1 (2003) 134-140
5. Peppel K., Crawford D., and Beutler B. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174 6 (1991) 1483-1489
6. Jarvis B., and Faulds D. Etanercept: a review of its use in rheumatoid arthritis. Drugs 57 6 (1999) 945-966
7. Bloquel C., Bessis N., Boissier M.C., Scherman D., and Bigey P. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-α soluble receptor variants. Hum Gene Ther 15 2 (2004) 189-201
8. Ghivizzani S.C., lechunman E.R., Kang R., Tio C., Kolls J., Evans C.H., et al. Direct adenovirus-mediated gene transfer of interleukin 1and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 95 8 (1998) 4613-4618
9. Mazda O. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors. Curr Gene Ther 2 3 (2002) 379-392
10. Makanishi H., Mazda O., Satoh E., Asada H., Morioka H., Kishida T., et al. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo. Gene Ther 10 21 (2003) 434-442
11. Xu C., Yao L., Zu D., Chen A., Huang G., Zhang Z., et al. Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc. Chinese J Biotechnol 18 2 (2002) 178-181
12. Okano M., Nishizaki K., Abe M., Wang M.M., Yoshino T., Satoskar A.R., et al. Stain-dependent induction of allergic rhinitis without adjuvant in mice. Allergy 54 6 (1999) 593-601
13. Hamid Q., Azzawi M., Ying S., Moqbel R., Wardlaw A.J., Corrigan C.J., et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87 5 (1991) 1541-1546
14. Terada N., Konno A., Tada H., Shirotori K., Ishikawa K., and Togawa K. The effect of recombinant interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol 90 (1992) 160-168
15. Enerback L., Pipkorn U., and Granerus G. Intraepithelial migration of mucosal mast cells in hay fever. Int Arch Allergy Appl Immunol 80 (1986) 44-51 (Abstr.)
16. Wilson J.B., Bell J.L., and Levine A.J. Expression of Epstein-Barr Virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. The EMBO J 15 12 (1996) 3117-3126
17. Simson L., and Foster P.S. Chemokine and cytokine cooperativity: eosinophil migration in the asthmatic response. Immunol Cell Biol 78 4 (2000) 415-422
18. Liu C.M., Shun C.T., and Cheng Y.K. Soluble adhesion molecules and cytokines in perennial allergic Rhinitis. Ann Allergy Asthma Immunol 81 2 (1998) 176-180
19. Erger R.A., and Casale T.B. Tumor necrosis factor alpha is a necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosiophil transendothelial migration. Int Arch Allergy Immunol 115 1 (1998) 24-32
20. Casale T.B., costa J.J., and Galli S.J. TNF alpha is important in human lung allergic reactions. Am J Respir Cell Mol Biol 15 1 (1996) 35-44
21. Bradding P., Feather I.H., Wilson S., Bardin P.G., Heusser C.H., Holgate S.T., et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 151 7 (1993) 3853-3865
22. Galli S.J., Gordon J.R., and Wershil B.K. Mast cell cytokines in allergic inflammation. Agents Actions Suppl 43 (1993) 209-220
23. Maezawa Y., Nakajima H., Kumano K., Kubo S., Karasuyama H., and Iwamoto I. Role of IgE in Th2 cell-mediated allergic airway inflammation. Int Arch Allergy Immunol 131 Suppl. 1 (2003) 2-6